UPCOMING EVENTS

NEWS

Erythromer, a nanoscale bio-synthetic artificial red cell

VJHemOnc Video Journal of Hematological Oncology Published on Dec 16, 2016 Press brief by Allan Doctor, MD of Washington University School of Medicine, St. Louis, MO, on erythromer (EM), a nanoscale bio-synthetic artificial red cell: proof of concept and In vivo...

read more

Bioengineering: Doing without donors | Nature

Featured in NATURE 28 SEPTEMBER 2017 | VOL 549 | NATURE Each year, at about 13,000 collection centres worldwide, phlebotomists stick needles in the veins of healthy volunteers and amass in excess of 110 million donations of blood. The volume collected is enough to...

read more

CONTACT US

info@kalocyte.com

670 West Baltimore Street
HSRF III, 8th Floor
Baltimore, Maryland 21201

ABOUT US

KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care and is poised to deliver ErythroMer, a dried, bio-inspired artificial red blood cell, to market. ErythroMer is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. KaloCyte is supported by over $20M in federal grants and investor funding.